2021 Archives
You are viewing archived information from 2021
Report Title: Department of Commerce and Consumer Affairs; Prescription Drugs; Price Increases; Notification; Insurance Commissioner
Description: Requires drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a sixteen per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame.
Companion:  HB17
Package: None
Current Referral: HTH, CPN
Introducer(s): BAKER, GABBARD, KEITH-AGARAN, KEOHOKALOLE, RHOADS, SAN BUENAVENTURA, Ihara, Kidani, Nishihara, Shimabukuro, Taniguchi

Sort by Date Status Text
2/10/2021SThe committee on HTH deferred the measure.
2/5/2021SThe committee(s) on HTH has scheduled a public hearing on 02-10-21 1:00PM in conference room Via Videoconference.
1/27/2021SReferred to HTH, CPN.
1/25/2021SPassed First Reading.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.

All Versions of this Measure

Committee Reports
No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.

Hearing Notices
2/10/21 1:00P
Via Videoconference